YPSN:SWX
Ypsomed Holding AG
CHF 434.40
arrow_downward
-1.41%(-6.20) 1D
Nov 20, 5:30:23 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YPSN...
Open
CHF 440.00
High
CHF 440.80
Low
CHF 430.80
Mkt. cap
5.71B
Avg. vol.
16.05K
Volume
18.44K
Dividend
1.01%
Quarterly dividend
CHF 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
34.47
52-wk high
CHF 447.80
52-wk low
CHF 260.50
EPS
CHF 12.60
Shares outstanding
13.15M
No. of employees
2K
Open
CHF 440.00
High
CHF 440.80
Low
CHF 430.80
Mkt. cap
5.71B
Avg. vol.
16.05K
Volume
18.44K
Dividend
1.01%
Quarterly dividend
CHF 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
34.47
52-wk high
CHF 447.80
52-wk low
CHF 260.50
EPS
CHF 12.60
Shares outstanding
13.15M
No. of employees
2K
News stories
From web sources and news partners
ING Sprinters
·
1 day ago
Uitverkoop AEX Index komt tot een einde
Nieuws.nl
·
21 hours ago
Stevige min voor AEX-index met flinke verliezen chipbedrijven
Welingelichte Kringen
·
2 days ago
AEX-index begint hoger, focus op beursgang AI-bedrijf Anthropic
The Defiant
·
4 minutes ago
Nasdaq Composite vs. Nasdaq-100: What Each Measures
Profile
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
About Ypsomed Holding AG
CEOSimon Michel
Employees2.2K
Founded2003
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteypsomed.com